All Terrain Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

All Terrain Financial Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-908	Closed	-$88K	–	255
2018 Q4	$88K	Buy	+908	New	+$96.4K	0.04%	166
2018 Q3	–	Sell	-1,310	Closed	-$144K	–	248
2018 Q2	$144K	Hold	1,310	–	–	0.06%	177
2018 Q1	$140K	Hold	1,310	–	–	0.06%	174
2017 Q4	$140K	Buy	+1,310	New	+$140K	0.06%	187

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

All Terrain Financial Advisors's IBB Position: Q1 2019 in Review

All Terrain Financial Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2019, closing a stake of 908 shares — an estimated $88K sold.

All Terrain Financial Advisors first reported a position in IBB in Q4 2017 and held it in 4 quarters. The position peaked at $144K in Q2 2018. 670 funds tracked by Wall St. Rank hold IBB as of Q1 2019.

All Terrain Financial Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2019 after selling out during the quarter.
All Terrain Financial Advisors sold 908 iShares Biotechnology ETF shares in Q1 2019, an estimated $88K.
All Terrain Financial Advisors first reported a position in iShares Biotechnology ETF in Q4 2017 and held it in 4 quarters.
All Terrain Financial Advisors's iShares Biotechnology ETF position peaked at $144K in Q2 2018.
670 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2019.

Based on All Terrain Financial Advisors's 13F filing for Q1 2019, filed 14 May 2019.